Karyopharm Therapeutics Inc. (KPTIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0254
-0.0001 (-0.39%)
At close: Nov 13, 2026
OTC-KPTIQ's stock price has decreased by -99.55% in the past year and price targets may not have had time to catch up.
Karyopharm Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Rodman & Renshaw | Rodman & Renshaw | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Nov 2, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $8 | Buy | Maintains | $8 | +31,396.06% | Oct 27, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $3.68 | Buy | Maintains | $3.68 | +14,388.19% | Sep 1, 2026 |
| Jefferies | Jefferies | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +43,207.09% | Jul 31, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jul 31, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $16 → $7 | Buy | Maintains | $16 → $7 | +27,459.06% | Jul 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades $13 → $3 | Hold | Downgrades | $13 → $3 | +11,711.02% | Jul 31, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Hold Reiterates $5 → $7 | Hold | Reiterates | $5 → $7 | +27,459.06% | May 15, 2026 |